(Q35551939)

8 August 2017

1 reference

title

Enzyme and proton-activated prodrugs for a selective cancer therapy (English)

1 reference

8 August 2017

Enzyme and Proton-Activated Prodrugs for a Selective Cancer Therapy (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.2174/1381612033454072

18 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529411

18 March 2024

1 reference

https://api.crossref.org/works/10.2174/1381612033454072

18 March 2024

author name string

L. F. Tietze

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529411

18 March 2024

T. Feuerstein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529411

18 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14529411

18 March 2024

publication date

1 January 2003

1 reference

full work available at URL

8 August 2017

http://eurekaselect.com/article/download/63667

1 reference

Crossref

DOI

https://api.crossref.org/works/10.2174/1381612033454072

Current Pharmaceutical Design

18 March 2024

published in

1 reference

8 August 2017

volume

9

1 reference

8 August 2017

issue

26

1 reference

8 August 2017

page(s)

2155-2175

1 reference

Duocarmycin SA, a new antitumor antibiotic from Streptomyces sp

8 August 2017

cites work

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.43.1037

Identifiers

DOI

1 reference

8 August 2017

1 reference